Armix Injection

Adult dosage

As a total amino acid, administer up to 1 to 1.5 g per kg of body weight daily by drip infusion. The infusion rate should be such that an approximate concentration of 10 g of total amino acids is delivered over 60 minutes, with an infusion rate of 30 to 40 drops per minute.

Children's dosage

For children, the dosage and infusion rate should be adjusted accordingly.

This medication must be used strictly according to a doctor's instructions. It should not be used in patients at risk for hepatic coma or those with severe kidney dysfunction, those with nitrogen metabolism issues, patients with severe heart failure or pulmonary edema, those with very little or no urine output, patients with hypernatremia or hyperchloremia, those with alkalosis, or patients with a history of myocardial infarction. It should be administered with caution in patients with severe acidosis, congestive heart failure, edema due to sodium retention, hyperkalemia, or those with liver and kidney disorders. This medication contains sodium bisulfite, which may cause allergic reactions or asthma attacks in some patients, necessitating caution. During use, symptoms such as rash, nausea, vomiting, palpitations, and elevated blood pressure may occur, and in severe cases, discontinuation should be considered. Caution is required as metabolic acidosis or other serious side effects may occur with large or rapid administration. Patients with impaired kidney or liver function should have their conditions monitored frequently through blood tests and other means. Electrolyte balance must be carefully monitored during large dosages, as excessive administration can lead to metabolic alkalosis. Excess fluid administration should be avoided in patients with kidney disease, lung disease, or severe heart disease. Diabetic patients should frequently monitor their blood sugar levels while using this medication. Interactions may occur when used with other medications, so consultation with medical personnel is essential. Pregnant women should only use this medication when the therapeutic benefits outweigh the risks, as its safety has not been established. When administering to children, the concentration should be lower, and particularly for infants, frequent monitoring of blood ammonia levels is necessary. Elderly patients should have the administration rate slowed down and the dose adjusted due to decreased bodily function. This medication contains electrolytes, requiring monitoring of electrolyte balance during administration, which should be done slowly intravenously. The injection should be adjusted to body temperature, and preparation and management must be done under aseptic conditions. Do not use the solution if it has changed color or leaked before use, and it is advisable to use it within 24 hours when stored in refrigeration without opening the package. Check the measurement markings on the container accurately before use, and do not use damaged containers.

Serious side effects

• Anaphylactic shock
• respiratory distress
• respiratory arrest
• shock
• bronchospasm

Mild side effects

• Rash
• nausea
• vomiting
• chest discomfort
• palpitations
• rapid heartbeat (tachycardia)
• elevated blood pressure
• chills
• fever
• headache

This medication should be stored in a sealed container to protect it from air and light exposure, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the drug's effectiveness.

Appearance

A colorless to slightly yellow transparent solution contained in a multilayer film plastic container or a glass container for infusion, in a polypropylene aqueous injection container.

Package unit

Bottle - 100 milliliters/bottle, Bottle - 180 milliliters/bottle, Bottle - 200 milliliters/bottle, Bottle - 250 milliliters/bottle, Bag - 100 milliliters/bag, Bag - 250 milliliters/bag